Acyclovir Injection, Solution
Product Images NDC 65219-622

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 65219-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Acy0a 0000 01)

Structural Formula (Acy0a 0000 01)
Chemical structure of acyclovir sodium salt, depicting its purine base with attached side chain and sodium ion (Na+). The structure shows nitrogen and oxygen atoms arranged in a heterocyclic ring system with an amino group and an ether-linked alcohol side chain.*
FDA Label Image

Fresenius Kabi Logo (Acy0a 0000 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Acyclovir Injection, USP label for intravenous use shows 500 mg per 10 mL (50 mg per mL) concentration. The label highlights that the product is for IV infusion only and must be diluted prior to use. The vial size is 10 mL, single dose. The manufacturer is Fresenius Kabi USA, LLC, Lake Zurich, IL. Additional instructions and storage conditions are partially visible.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Acyclovir 500 mg per 10 mL injection, USP, in a carton label for intravenous use. The sterile, nonpyrogenic solution contains 50 mg/mL acyclovir sodium equivalent. The package contains 10 single-dose 10 mL vials. Labeler is Fresenius Kabi USA, LLC, with storage and dilution instructions included on the label.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Acyclovir Injection, USP 50 mg/mL intravenous solution in a 20 mL single-dose vial by Fresenius Kabi USA, LLC. The label indicates a total of 1,000 mg per 20 mL, specifies the need for dilution prior to use, and states the product is for IV infusion only with Rx only status. Storage instructions and barcode are also shown.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Acyclovir Injection, USP 1,000 mg per 20 mL (50 mg/mL) intravenous solution label for Fresenius Kabi USA, LLC. The label indicates single dose vials, must be diluted prior to use for IV infusion only, with a pack quantity of 10 x 20 mL vials. It includes sterility and nonpyrogenic statements, pH range, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.